Latine
Latine
Product Description
| Nomen anglicum | Uracil |
| Seres Alias | 2,4(1H,3H)-Pyrimidinedione |
| CAS RN | 66-22-8 |
| Formulae hypotheticae | C₄H₄N₂O₂ |
| M. Pondus | 112.09 |
| EINECS No. | 200-621-9 |
| Formulae structurales | ![]() |
| Technical Indicatores Uracil (Pharmaceutical Medium) | |
| Item | Qualitas Index |
| Property | Alba vel off-alba crystallina pulveris |
| Damnum in remittit (%) | ≤ 0.5 |
| Residere in Ignition (%) | ≤ 0.1 |
| Lepidium sativum | Retentionis tempus praecipuum apicem solutionis testium congruere debet cum solutionis relationis (± 2.5%). |
| Chloride (%) | ≤ 0.01 |
| Sulfate (%) | ≤ 0.04 |
| Metalla gravia (ppm) | ≤ 10 |
| Puritas (%) | ≥ 99.0 |
| Liquefactio Point | 300℃ |
| Applicationem | Adhibetur ut pharmaceutical medium |
| Packaging | Interior packaging: PE bag; Externe packaging: cardboard tympanum vel packaging per mos requisita |
| Transportatio | Vehicula vecturae munda et sicca esse debent. Per onerariam, contra pluviam, umorem, solem, protege. Ne una cum substantiis toxicis, noxiis, corrosivis, aliisve pollutis transvehendis. Cura tractate in repositione et translatione; tionem vel bumping stricte prohibetur. |
| Repono et Lorem | Productum hoc in vase obsignato debet condi. Serva in bene ventilata, horreis siccis a sole directo. |
Maximum tentamen puritatis idoneum ad usum diam
Optima solutio in alcohole et basi solutiones
Consistent particulae magnitudo ad reproducibilem reactionem motuum
Usus in uridine et thymine derivativae synthesis
Enzyme in RNA polymerase et nucleotide metabolismi subiecta
Medium in pharmaceutical R&D ac denique chemicals
Xinxiang Ruicheng Technology Co, Ltd.
+86 188 3735 9388
+86 188 3735 9388
Orientem Qinglong Road, Xinxiang Oeconomica ipsum Zonam, Xinxiang, Henan, China
Iura omnia reservantur © Xinxiang Ruicheng Technologiae Societas, Ltd. | Index situs | Index situs |